New treatment for children with HIV shows promise
Roger Shapiro, professor of immunology and infectious diseases, discusses his recent study of a new treatment option for children living with HIV.
Experts reflect on COVID-19, share lessons for future pandemics
The U.S. response to the COVID-19 pandemic was full of missteps—ones that experts say can inform preparations for future global health emergencies.
Science fueled by social justice
Sydney Stanley, PhD ’23, researches infectious diseases with an eye toward improving the health of the world’s most vulnerable populations
PEPFAR program marks 20 years, 20 million lives saved
PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.
Failure of tuberculosis treatment linked to bacterial resilience
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Is new malaria vaccine ‘world-changing’? Maybe.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.
Experts offer tips on taking COVID rapid tests
Experts have been urging people to take advantage of rapid COVID tests and have offered advice on how to use them most effectively.
Coronavirus (COVID-19): Press Conference with Stephen Kissler, 3/23/22
You're listening to a press conference from the Harvard T.H. Chan School of Public Health with Stephen Kissler, research fellow in the Department of Immunology and Infectious Diseases. This call was recorded at 12:30 p.m. Eastern Time on…
‘The infectious disease that nobody ever thinks about’
To mark World TB Day, March 24, Harvard Chan School's Sarah Fortune, a TB expert, discusses the state of the disease worldwide, obstacles to fighting it, and the latest research.
Science unclear around fourth COVID-19 shot
Several countries have authorized second booster shots of COVID-19 vaccine, but concerns have recently been raised about whether this is a useful approach.